Page last updated: 2024-10-17

3,4-dihydroxyphenylacetic acid and Chronic Fatigue and Immune Dysfunction Syndrome

3,4-dihydroxyphenylacetic acid has been researched along with Chronic Fatigue and Immune Dysfunction Syndrome in 1 studies

3,4-Dihydroxyphenylacetic Acid: A deaminated metabolite of LEVODOPA.
(3,4-dihydroxyphenyl)acetic acid : A dihydroxyphenylacetic acid having the two hydroxy substituents located at the 3- and 4-positions. It is a metabolite of dopamine.
dihydroxyphenylacetic acid : A dihydroxy monocarboxylic acid consisting of phenylacetic acid having two phenolic hydroxy substituents.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Thakur, V1
Jamwal, S1
Kumar, M1
Rahi, V1
Kumar, P1

Other Studies

1 other study available for 3,4-dihydroxyphenylacetic acid and Chronic Fatigue and Immune Dysfunction Syndrome

ArticleYear
Protective Effect of Hemin Against Experimental Chronic Fatigue Syndrome in Mice: Possible Role of Neurotransmitters.
    Neurotoxicity research, 2020, Volume: 38, Issue:2

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Anxiety; Behavior, Animal; Brain; Disease Models, Animal; D

2020